Boston Scientific (BSX) Enterprise Value (2009 - 2026)

Boston Scientific has disclosed Enterprise Value across 18 years of filings, most recently posting $61.6 billion for Q2 2026.

• In Q2 2026, Enterprise Value fell 61.25% year-over-year to $61.6 billion; the TTM figure through Jun 2026 stood at $61.6 billion (down 61.25% YoY), while the FY2025 annual figure was $139.8 billion, up 6.33% from the prior year.
• Enterprise Value came in at $61.6 billion for Q2 2026 at Boston Scientific, down from $92.1 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $158.9 billion in Q2 2025 to a low of $53.1 billion in Q2 2022.
• Average Enterprise Value over 5 years is $97.5 billion, with a median of $88.1 billion recorded in 2026.
• Year-over-year, Enterprise Value soared 58.21% in 2024 and plunged 61.25% in 2026.
• Over 5 years, Enterprise Value stood at $65.5 billion in 2022, then advanced by 28.62% to $84.2 billion in 2023, then surged by 56.12% to $131.4 billion in 2024, then advanced by 6.33% to $139.8 billion in 2025, then plunged by 55.96% to $61.6 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $61.6 billion in Q2 2026, $92.1 billion in Q1 2026, and $139.8 billion in Q4 2025.